WAY-262611
Dostawca: ENZO LIFE SCIENCES
BMLWN1100005
BMLWN1100025
ENZOBMLWN1100005EA
740
PLN
ENZOBMLWN1100005
ENZOBMLWN1100025
WAY-262611
WAY-262611
DKK1 inhibitor
Wnt pathway agonist acting via inhibition of Dkk1 with no GSK-3β inhibition. TCF-Luciferase EC50=0.63µM. WAY262611 was able to enhance trabecular bone formation rate in the tibia of OVX rats following oral administration.
Formuła:
C₂₀H₂₂N₄ |
Numer MDL:
MFCD20527803 Numer CAS: 1123231-07-1 |
|
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...